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A randomised controlled trial evaluated bright light t erapy and morning activity for 
the treatment of Delayed Sleep-Wake Phase Disorder (DSWPD) in young people. 60 
adolescents and young adults (range= 13-24 years, mean= 15.9±2.2 y, 63% f) diagnosed with 
DSWPD were randomised to receive three weeks of post-awakening Green Bright Light 
Therapy (~507nm) and Sedentary Activity (sitting, watching TV), Green Bright Light 
Therapy and Morning Activity (standing, playing motion-sensing videogame), Red Light 
Therapy (~643nm) and Sedentary Activity or Red Light T erapy and Morning Activity. 
Sleep (ie sleep onset time, wake up time, sleep onset latency, total sleep time) and daytime 
functioning (ie morning alertness, daytime sleepiness, fatigue, functional impairment) were 
measured pre-treatment, post-treatment and at one and three month follow-up. Contrary to 
predictions, there were no significant differences in outcomes between treatment groups; 
interaction effects between treatment group and time for all outcome variables were not 
statistically significant. However, adolescents andyoung adults in the morning activity 
conditions did not meaningfully increase their objective activity (ie movement frequency). 
Overall, adolescents reported significantly improved sleep timing (d=0.30-0.46), sleep onset 
latency (d=0.32) and daytime functioning (d=0.45-0.87) post-treatment. Improvements in 
sleep timing (d=0.53-0.61), sleep onset latency (d=0.57), total sleep time (d=0.51), and 
daytime functioning (d=0.52-1.02) were maintained, or improved upon, at the three month 
follow-up. However, relapse of symptomology was common and 38% of adolescents and 
young adults requested further treatment in addition to the three weeks of light therapy. 
Although there is convincing evidence for the short-te m efficacy of chronobiological 
treatments for DSWPD, long-term treatment outcomes can be improved. To address this gap 
in our current knowledge, avenues for future research e discussed.  
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Clinical Trial: Australian & New Zealand Clinical Trials Registry, 








































Delayed Sleep-Wake Phase Disorder (DSWPD) arises whn the endogenous circadian 
rhythm and sleep timing of individuals is significantly later than what is generally accepted 
by modern society (American Academy of Sleep Medicine [AASM], 2014). DSWPD 
presents as the inability to initiate sleep at a desired clock time and difficulty waking to fulfil 
morning requirements. DSWPD is estimated to affect b tween 1-16% of adolescents (AASM, 
2014; Lovato et al. 2013).  
Changes in sleep occur throughout puberty, placing adolescents at particular risk of 
DSWPD. There is a widespread and consistent tendency for later bedtimes (Crowleyet et al. 
2007; Gradisar et al. 2011), driven by reduced homeostatic sleep pressure across waking and 
delayed circadian timing (ie relative to younger school-aged children, Gradisar. Crowley, 
2013). Compounding obligations (eg study, part-time work, extra-curricular pastimes) 
increase the number of tasks adolescents and young adults need to complete before sleep 
(Carskadon, 2011; Gradisar, Crowley, 2013) and lessening of parent-set bedtimes may permit 
later bedtimes (Gangwisch et al., 2010; Short et al., 2011). When waking for school, this 
leads to sleep restriction and impaired daytime functio ing (Lovato et al., 2013; Shochat, et al 
2014; Sivertsen et al. 2015; Wilhelmsen-Langeland et al., 2013). Due to the prevalence and 
impact of DSWPD on adolescents and young adults, it i  important to ensure efficacious 
treatments are available.  
Current treatments include behaviourally-based methods to manipulate circadian 
timing (eg bright light therapy (BLT), exogenous melatonin) (Gradisar et al. 2014). However, 
clinical trials evaluating the efficacy of treatments for DSWPD are rare. There is weak 
evidence supporting the use of strategically timed elatonin (Eckerberg et al. 2012; Saxvig et 
al., 2014; van Geijlswijk et al. 2010; van Maanen, Dewald-Kaufmann et al. 2013) or 
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et al., 2015; Danielsson et al. 2015; Gradisar et al., 2011; Saxvig et al., 2014). However, the 
degree of phase advancement can be influenced by light timing (Crowley,  Eastman, 2017; 
Khalsa et al. 2003), duration (eg ≥30 mins; Geerdink et al. 2016; Gradisar, Dohnt, et al., 
2011; Saxvig et al., 2014), illuminance (eg ≥117 lux; Cajochen et al., 2005) and wavelength 
(eg shorter>longer; Warman et al. 2003; Wright et al. 2004). Portable light devices (ie light 
glasses, light visors) have been recently developed and may be more practical for adolescents 
and young adults preparing for school, university or w rk (Bonnar et al., 2015). However, 
there is insufficient evidence to support their usein treatment (Auger et al., 2015). 
Additionally, although short wavelength light is thought to be superior in the treatment of 
circadian rhythm sleep disorders, there is a lack of clinical research to support this hypothesis 
(Auger et al., 2015).  
There is also a paucity of research relating to many new areas of enquiry, for 
example, scheduled physical activity (Auger et al., 2015). Individuals with DSWPD are 
active late at night and relatively inactive in themorning (ie 8-11am) (Joo et al., 2017), which 
may perpetuate delayed sleep-wake timing. Nocturnal exercise delays circadian timing 
(Baehr et al., 2003; Baehr et al., 1999; Barger et al., 2004; Buxton et al., 1997; Eastman et al., 
1995; Van Reeth et al., 1994; Youngstedt et al., 2002), whereas exercise administered at other 
times of the day may result in phase advances (Richardson et al., 2017), particularly when 
advanced in small daily increments (ie 20 mins) (Miyazaki et al., 2001). Therefore, it is 
possible that post-awakening morning activity, when combined with gradually earlier wake-
up times, may help to phase advance the circadian and sleep timing of young people with 
DSWPD. This protocol overlaps that of BLT for DSWPD (Gradisar et al., 2014). Given that 
BLT can now be delivered by portable, wearable glasses, it is possible that the addition of 
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Increased morning activity may also have therapeutic implications for the daytime 
functioning of adolescents and young adults with DSWPD, as there is some evidence for the 
relationship between postural change, thermoregulation (ie changes in body temperatures) 
and alertness (Krauchi et al., 1997). Adolescents with good sleep hygiene experience benefits 
in sleep (ie SOL, deep slow-wave sleep), mood, daytime concentration and sleepiness, after 
running for 30 mins at moderate intensity for five days per week before school, over three 
weeks (Kalak et al., 2012). These findings suggest that if bright light therapy is combined 
with physical activity adolescents and young adults wi h DSWPD may experience additional 
benefits to sleep and daytime functioning.  
Clinical guidelines place importance on replicating laboratory-based research within 
less tightly controlled field settings (Auger et al., 2015). Therefore, the present randomised-
controlled study aimed to evaluate the efficacy of BLT delivered by portable short-
wavelength light glasses, and whether supplementing BLT with morning activity enhances 
treatment outcomes for adolescents and young adults with DSWPD. Outcomes of interest 
include sleep timing (ie sleep onset time, wake up time), sleep latency, total sleep time and 
daytime functioning (ie morning alertness, daytime sleepiness, fatigue, functional 
impairment). To extend upon a recent trial comparing bright broad-spectrum white light 
(active treatment) with dim red light (control condition), we compared the efficacy of green 
(short) wavelength light, to red (long) wavelength lig t. Within each of these conditions, 
participants were randomly allocated to complete physical activity (standing, playing motion-
sensing videogame) or sedentary activity (sitting, watching TV) during morning LT. It was 



















455 families made contact with the Child & Adolescent Sleep Clinic following 
referral from GPs, or in response to community advertisements (Figure 1). 164 adolescents 
and young adults met age criteria for inclusion and83 were assessed. Of these, 63 met ICSD-
3 (AASM, 2014) criteria for DSWPD, and 60 were randomised into the study (mean= 
15.9±2.2 y, 63% f). The trial was registered with the Australian and New Zealand Clinical 
Trials Registry (ACTRN12614000308695) and approved by the Southern Adelaide Clinical 
Human Research Ethics Committee (Application Number 165.14). 
Inclusion criteria for the study were as follows: participants aged between 13-24 
years1, and primary diagnosis of DSWPD. This age range of participants was chosen, as 
adolescents and young adults are biologically driven to have later chronotypes (Roenneberg 
et al., 2004), and it is common for young adults in Australia to reside with their parents, thus 
they were not considered distinct phenomenological groups. Participants were not excluded 
for psychological comorbidity, given its prevalence in individuals with DSWPD (Reid et al., 
2012; Sivertsen et al., 2015), which enhances the gen ralisability of findings (Wilhelmsen-
Langeland et al., 2013). However, severe suicidal ideation led to exclusion.  
Adolescents and young adults were randomly allocated to receive Green BLT and 
sedentary activity (SA) (N=15, mean age= 15.9±1.8 y, 60% f), Green BLT and morning 
activity (MA) (N=15, mean= 16.2±2.8 y, 67% f), Red LT and SA (N=15, mean= 15.5±1.6 y, 
67% f) or Red LT and MA (N=15, mean= 15.7±2.8 y, 60% f). Groups did not differ in terms 
of age, F (3,56) = 0.22, p=.88, or gender distribution, χ²(1, N = 60) = 0.29, p= 0.96.   
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Materials and Apparatus 
Clinical Sleep History Interview (CSHI) 
A revised semi-structured interview (Gradisar, Dohnt, et al., 2011) was used to 
diagnose DSWPD, as per the ICSD-3 (AASM, 2014). The CSHI elicited information 
pertaining to Criterion A (chronic difficulty initiating sleep and awakening); Criterion B 
(present for ≥three months) and Criterion E (differential diagnosis). In terms of quantifying 
the severity of delay in sleep timing, participants self-reported their ad libitum wake up time 
(ie wake up time on days they do not have morning commitments) and their required wake up 
time (eg to attend school, university, work), in the clinical sleep history interview. 
Adolescents and young adults reported an ad libitum wake up time (mean=11:28am±1.76hr) 
significantly later than the wake up time required to fulfil morning commitments 
(mean=7:30am±1.15hr). Sleep diaries were also used to confirm a delay in the timing of the 
habitual sleep period. 
Sleep Diary 
 Sleep diaries are considered essential for DSWPD diagnosis, (AASM, 2014). 
The daily online sleep diary measured sleep timing, sleep onset latency (SOL), wake after 
sleep onset (WASO) and total sleep time (TST). Sleep parameters were averaged for school 
nights (Sun-Thurs) and weekend nights (Fri-Sat) separately. Daily sleep diaries completed 
throughout treatment also required participants to self-report the duration (mins) of morning 
light therapy and activity completed.  
Wrist Actigraphy 
 Participants wore a MicroMini Motionlogger wrist actigraphy monitor (Ambulatory 
Monitoring Inc., Ardsley, NY) for one week following the assessment, and for the three 
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min epochs. Actigraphy is useful for identifying sleep problems caused by mistimed 
circadian rhythms and is sensitive to improvements in sleep as a result of treatment (Ancoli-
Israel et al., 2003). Adolescent’s sleep onset timeand offset time were scored using an 
algorithm validated for adolescents (AMI-Sadeh, Action 4, Ambulatory Monitoring Inc, 
Ardsley, NY) (Meltzer et al. 2012; Sadeh et al.,1994), to confirm delayed sleep timing at 
baseline (Criterion D), and to monitor changes across treatment. Motor activity for the hour 
after awakening (ie activity frequency count per one min epoch) was also scored to confirm 
compliance with allocated morning activity. For data to be included in analysis, participants 
needed to have at least three days of actigraphy recording per school week (Acebo et al., 
1999). An increase in post-awakening motor activity from baseline to treatment was the 
criteria for compliance with the physical activity ntervention, whereas stabilisation, or a 
reduction, of physical activity was anticipated for participants within the sedentary activity 
conditions.  
Sleepiness and Fatigue 
Sleepiness and fatigue are distinct daytime consequences of inadequate adolescent 
sleep (Shen et al. 2006; Short et al., 2013). The Pediatric Daytime Sleepiness Scale (PDSS) is 
an eight item self-report scale of daytime sleepiness ( g “How often do you fall asleep or feel 
drowsy in class?”; zero=“Never”, four= “Always”) (Drake et al., 2003). Total scores range 
from 0-32, with higher scores indicating higher sleepiness. Drake and colleagues (2003) 
reported good internal consistency (Cronbach α = 0.80); however, reliability was lower in the 
current study (Cronbach α = 0.57).  
The Flinders Fatigue Scale (FFS) is a seven item self-report measure of global fatigue 
(eg “Was fatigue a problem for you?”; zero=“Not at all”, four=“Extremely”) (Cameron et al., 
2017; Gradisar et al., 2007). Total scores range from 0-31, with higher scores indicating 
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Adolescents and young adults provided a daily rating of morning alertness, using a 
five point Likert scale with pictorial stimuli (eg “which face best describes how you are 
feeling one hour after waking up in the morning”) (Maldonado et al., 2004). Scores ranged 
from one-five, with higher scores indicating higher alertness.    
Functional Impairment  
Individuals with DSWPD report lifestyle impairment (Giannotti et al., 2002; Micic et 
al., 2015; Rajaratnam et al., 2015; Saxvig et al., 2012). The Sheehan Disability Scale (SDS) is 
a five item measure of functional impairment (eg “To what extent has your sleep pattern 
disrupted your school work”; 0=“Not at all”, 10=“Extremely”) (Sheehan et al., 1996). 
Participant also reported the number of missed and under-productive days/week (zero-seven). 
Total scores range from 0-47, with higher scores indicating more impairment. The SDS had 
adequate reliability (Cronbach α = 0.71). 
Portable Light Glasses 
Re-Timers (ie glasses with two LED lights on the bottom frame, per eye; Re-time Pty 
Ltd., Adelaide, Australia) were the light source for LT. Participants received either 
commercially available green light (~507nm) glasses on the highest setting (~112 lux per 
diode at two cm distance2), or Re-timer frames, altered to emit red light (~643nm), on the 
lowest setting (~54 lux per diode at two cm distance) (spectrometer: Ocean Optics, Florida, 
USA; lux meter: A.P.C.S., NSW, Australia). Discounting the wavelength of light emitted, the 
glasses looked otherwise identical for both treatment conditions. As the human circadian 
rhythm is least sensitive to long-wavelengths of light (Wright et al., 2004), red light was used 
as a control condition (Saxvig et al., 2014). All participants were asked to draw curtains and 
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blinds in the home during LT, reducing ambient light and isolating light emitted from the 
glasses.  
Morning Activity 
Adolescents and young adults in the morning activity conditions were asked to 
complete 30-60 mins of mild physical activity during LT. Physical activity involved playing a 
motion-sensing videogame (eg, XBox Kinect, Nintendo Wii, Playstation Move), whilst 
standing upright. This modality was chosen, as videogames are played indoors (ie, not 
weather-affected) and adolescents were anticipated to njoy this activity. Active videogames 
increase heart rate, oxygen consumption and energy expenditure in adolescents, relative to 
sedentary videogames (Graves et al., 2008; Peng et al., 2011) and are more enjoyable relative 
to walking/ jogging (Graves et al., 2010). Adolescents and young adults in the sedentary 
conditions remained seated, watching TV for 30-60 mins. It was anticipated that participants 
received the same amount of light emitted from the tel vision and thus, screen light was 
controlled across conditions.  
Sleep Therapy 
All treatment groups received three, weekly 50-minute one-on-one therapy sessions, 
delivered by the same psychologist who conducted th initial assessment (ie a clinical, 
registered or provisional psychologist). The first session consisted of psychoeducation about 
circadian rhythms, instructions to reduce evening light two hr prior to bed and plans for 
morning LT. Adolescents and young adults were instructed to sleep-in until their natural 
wake time to begin treatment (Gradisar, et al., 2011; Saxvig et al., 2014). Participants wore 
the portable light glasses for 30-60 mins immediately after rising from bed each day and 
commenced LT 30-mins earlier each subsequent day, until they reached a wake-up time of 
06:00 (Gradisar et al., 2014). Treatment was completed on school mornings and weekends. If 
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patterns were stabilised, with a wake-up time no later than 7:30am. Adolescents and young 
adults were instructed to complete their allocated morning activity for the same duration and 
at the same time as LT. To prevent relapse following cessation of LT, participants were 
instructed to continue to minimise evening light, avoid sleeping in and seek ambient light 
after awakening (Gradisar et al., 2014).  
Procedure 
 Recruitment occurred from July 2014 to December 2016. 83 adolescents and young 
adults underwent an assessment with a clinical, registered or provisional psychologist, 
consisting of the CSHI, seven day sleep diary and questionnaires3. Participants wore an 
actigraphy wristwatch and completed another sleep diary and questionnaires between the 
assessment and first treatment session (Gradisar et al., 2014). DSWPD diagnosis was 
confirmed at a consensus meeting between therapists and the clinic supervisor (MG). 
Participants deemed eligible were randomly allocated into one of four treatment conditions, 
using a block randomisation schedule, and completed thr e weekly sleep therapy sessions 
with a psychologist. Sleep diaries and questionnaires were completed across treatment and at 
one and three month follow-up. An abridged version of the CSHI was administered at three 
month follow-up to re-assess DSWPD diagnosis. 
 Statistical Analyses 
 To minimise the potential impact of missing data (~25% from pre-treatment to three 
month follow-up), Linear Mixed Modelling (LMM) was used to analyse data (Landau, 
Everitt, 2004). Effect sizes (Cohen’s d) were calculated to establish the magnitude of within- 
and between-subjects differences. Cohen’s d was calculated as d=M1-M2/(SDpooled).  
                                                          
3 The sleep diary and questionnaires completed priorto the assessment were for diagnostic purposes only and 
were not included in data analysis. Pre-treatment data were collected over seven days/nights following the 



















Clinical Features of Adolescents and Young Adults with DSWPD 
Most adolescents and young adults reported their sleep problem occurred gradually 
(88%), with mean chronicity of three years months. See Table 1 for clinical presentation, as 
per clinical sleep history interview. 66% of participants reported a diagnosed psychological 
condition, with anxiety (45%) and depression (43%) most common. Distribution of 
psychological comorbidity between groups was similar, χ²(1, N = 59) = 0.32, p= 0.10. 
Participants were taking medication to treat mood (n=15, Endep, Seroquel, Lexapro, etc.), 
sleep (n=7, melatonin, circadin rhythm) and asthma (n=7, Ventolin). Medication timing and 
dosage remained consistent, except melatonin/circadin rhythm, which were ceased prior to 
treatment. Adolescents and young adults receiving psychological intervention ceased therapy 
during the sleep trial. Treatment effects did not differ based on medication use or 
psychological co-morbidity and therefore were not controlled for in final analyses. Four 
adolescents who withdrew prior to treatment completion reported significantly lower baseline 
sleep diary total sleep time, t(57) = -3.00, p=.004, d= 1.75, and sleep efficiency, t(57) = -2.45, 
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Table 1  
 
Clinical Presentation of Adolescents and Young Adults with DSWPD. 
Primary Sleep Problem Daytime Impairments∗ 
Difficulty falling asleep (68%) Tired/ fatigued (98%) 
Difficulty waking (15%) Daytime sleepiness (93%) 
Unrefreshing sleep (7%) Poor attention/ concentration/ memory (93%) 
Night time awakenings (5%) Low energy/ motivation (85%) 
Daytime consequences (5%) Moody/ irritable (82%) 
Secondary Sleep Problem Worries about sleep (68%) 
Difficulty waking (50%) Poor school performance (65%) 
Night time awakenings (23%) Somatic complaints (55%) 
Difficulty falling asleep (20%) Problems socialising (48%) 
Daytime consequences (7%) 
Past Sleep Problem/s 
Accident prone (40%) 
Behavioural issues (ie, hyperactivity) (37%) 
Incidence of past sleep problem (e.g., chronic 
insomnia disorder, bedtime resistance) (28%) 
Parental presence required to sleep in 
primary schooling (25%) 
 
Repeatedly woken in morning (68%) 
Frequent lateness to school, university or 
work (68%) 
* Participants could select more than one daytime impa rment. 
Treatment Compliance 
 Similarly to the self-reported estimation of ad libitum wake up time (ie during clinical 
sleep history interview, 11:28am±1.76hr), participants woke at 11.04am±1.7hr on the first 
morning of therapy, with no significant difference in therapy start point between groups, 
F(3,56)= 1.60, p=0.20). On average, participants completed therapy across 13.89days±4.47. 
Duration of therapy did not differ significantly between groups, F(3,53)= 0.848, p=0.47. 
There was also no significant difference in self-reported duration of daily LT between groups 
(F(3,50)= 0.146, p=0.93). However, duration of use reduced between treatment week one  
(M=32min, SE=2) and two (M=31min, SE=2) to week three (M=15min, SE=2, F(2,49)= 
20.14, p<0.001). This is due to some participants reaching a six am wake-up time and ceasing 
use of the light glasses in the final treatment week.  
18.4% of participants reported experiencing side eff cts related to use of the light 
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49) = 0.76, p= 0.86. Participants reported brief change in visual colour perception, following 
cessation of light therapy (n=7), mild headaches (n=4), watery/ sore eyes (n=2) and light 
aversion (n=1), however these symptoms were not severe enough for participants to opt out 
of light therapy.  
There were no between group differences for self-report d daily activity duration 
(F(3,52)= 0.969, p=0.41).  Activity duration also reduced from treatment week one 
(M=27min, SE=2) and two (M=27min, SE=2) to week three (M=16min, SE=2, F(2,49)= 
8.247, p=0.001). Motor activity for the hour after awakening showed a small decrease in 
activity from baseline across the first two weeks of treatment, for the Green BLT + Sedentary 
group (d=-0.31). However, changes in activity frequency for the Red LT + Sedentary (d=-
0.13), Green BLT + Activity (d=-0.06) and Red LT + Activity groups (d=0.12) were 
negligible, and there were no significant between-group differences, F(3,29)= 1.62,p=0.206. 
Results were similar when activity frequency was analysed separately for the first 30 min 
after awakening. These findings suggest the experimental manipulation did not lead to a 
meaningful increase in physical activity. 
Treatment  
 Figures 2 to 4 show changes in sleep diary sleep, actigraphy sleep timing and daytime 
functioning, respectively. Descriptive statistics are presented in full in Appendix A. Contrary 
to predictions, there were no differences among the four groups; interaction effects 
(group*time) for all outcome variables were not stati ically significant (p>0.05). However, 
main effects of time were found for all variables, xcept bedtime and WASO.  
From pre- to post-treatment, across all groups, adolescents demonstrated significant 
improvements for SOL, SOT and WUT, and a 47min improvement in TST (Figure 2). 
Actigraphy defined SOT and WUT also showed significant improvement (Figure 3; ie 39 
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sleepiness, fatigue and functional impairment improved from pre- to post-treatment (Figure 
4).  
 
Figure 2 Mean school night sleep diary (A) sleep onset time, (B) wake-up time, (C) sleep onset 
latency and (D) total sleep time, across treatment and follow-up. Error bars were excluded as there 
were no between-group differences and inclusion led to visual overcrowding. As there were no 



















Figure 3 Mean actigraphy school night (A) sleep onset time and (B) wake-up time for treatment 
groups across treatment. Error bars were excluded as there were no between-group differences and 
inclusion led to visual overcrowding. As there were no between-group differences, inferential 
statistics reported relate to the main effect of time. 
 
Figure 4 Mean (A) morning alertness across treatment and mean (B) daytime sleepiness, (C) fatigue 
and (D) functional impairment across treatment and follow-up. Error bars were excluded as there were 
no between-group differences and inclusion led to visual overcrowding. As there were no between-

















Adolescents and young adults maintained improvements for SOL, SOT, WUT, TST, 
sleepiness, fatigue and impairment at follow-up4. Forty percent of participants (N=24) 
completed a sleep diary, questionnaires and abridged clinical interview at the three month 
follow-up. There was no significant difference in pro ortion of DSWPD diagnosis between 
the groups (Table 2). However, partial relapse was common, with many adolescents and 
young adults reporting DSWPD symptomology at follow-up.  
Table 2  
 
Proportion of Adolescents and Young Adults who Report d Symptoms of DSWPD at Follow-up. 
 Green BLT 
+ SA  
(n=8) 
Green BLT 
+ MA  
(n=8) 
Red BLT  
+ SA  
(n=5) 
Red BLT  





DSWPD Criteria Met 
(Clinician Assessed) 
25% 25% 0% 0% 0.399 
Sleep-Onset Difficulties 38% 38% 40% 33% 1.00 
Difficulty Awakening 50% 88% 60% 33% 0.288 
Sleep Problem 
(Participant Reported) 
43% 38% 40% 0% 0.596 
 
38% of all participants requested further treatment, in addition to the three sessions of 
light therapy and activity. Once participants received additional treatment, they were 
withdrawn from the study and did not complete any further research follow-ups. There were 
no differences between groups, in terms of the proportion of participants who received 
additional treatment (Table 3). Additional treatment consisted of further BLT (n=4), 
exogenous melatonin (=3) or both (n=9), motivational interviewing (n=2), cognitive therapy 
(n=2), sleep restriction therapy (n=1), sleep hygiene (n=1) and behavioural modification for 
evening technology use (n=1).  
                                                          






















Green BLT  
+ SA  
(n=14) 
Green BLT  
+ MA  
(n=13) 
Red BLT  
+ SA  
(n=14) 
Red BLT  
+ MA 
 (n=15) 
Post-Treatment n=3 n=2 n=1 n=5 
1-Month Follow-Up n=1 n=0 n=4 n=1 
3-Month Follow-Up n=2 n=1 n=0 n=1 
Total                                                                                                                        43%* 23%* 36%* 47%* 
* χ²(3, N = 56) = 0.18, p= 0.60. 
Discussion 
 A randomised controlled design evaluated the efficacy of bright light therapy, 
delivered by portable LED glasses (ie Re-Timers), and morning activity for the treatment of 
adolescent DSWPD. There were no differences between the active and control conditions; 
however, over time, improvements were found across a range of night time and daytime 
variables (13 out of 15). Sleep timing was advanced and sleep quality and daytime 
functioning also improved, with these changes maintained at follow-up. 
Given adolescents and young adults had experienced their sleep problem for ~three years, 
five months, with significant associated daytime consequences, these results suggest that 
brief sleep therapy can result in rapid improvements i  adolescent’s sleep and wellbeing.  
Light Therapy 
These findings are consistent with results from previous RCTs of LT for adolescent 
DSWPD (Danielsson et al., 2015; Gradisar, Dohnt, et al., 2011; Saxvig et al., 2014). 
However, these studies used either light lamps/ boxes (ie 10,000 lux lamp, with 18 x 28 x 44 
cm surface, at 50 cm distance for 30-45 min, (Danielsson et al., 2015); 10,000 lux light box, 
with 47 x 17.5 x 29cm surface, at 50cm distance for 30-45 mins (Saxvig et al., 2014), or 
natural ambient light supplemented by light lamps (Gradisar, Dohnt, et al., 2011). Therefore, 
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developed portable light glasses for the treatment of DSWPD in young people and 
additionally, by being the first RCT for DSWPD to cmpare the efficacy of short green 
wavelength light therapy with long red wavelength lig t therapy.  
Experimental studies have provided convincing evidence for the superiority of short 
wavelengths of light (relative to long) in advancing the human circadian rhythm (Warman et 
al., 2003; Wright et al., 2004). However, clinical practice guidelines have called for the 
replication of experimental research findings in cli i al samples, within less tightly controlled 
environments (Auger et al., 2015). Initial data (Saxvig et al., 2014) suggest the wavelength of 
LT, when administered in accordance with practice guidelines, may not significantly 
influence the outcome of treatment for young people with DSWPD. Notably, experimental 
studies have administered shorter wavelength light ( e blue light, 470nm, Wright et al., 2004), 
compared to the present study (507nm). However, thee is some concern that short 
wavelength light below 500nm may cause photochemical damage to the retina (Bullough, 
2000). Therefore, commercially available light emitting devices, such as the Re-Timer, emit 
light above 500nm to avoid potential hazard, whilst a o maximising the degree of phase 
advance (Wright et al., 2004). The Re-Timer glasses have shown to phase delay the circadian 
rhythm of good sleepers, however experimental studies investigating phase advance are 
lacking (Lovato, Lack, 2015). It is possible this methodological difference (ie the wavelength 
of short wave light administered) may go some way to explaining the inconsistency in results 
between experimental and clinical research. However, it is also possible that changes in 
behavioural patterns alone (ie fixed earlier sleep-wake routine, evening light restriction) 
contributed to advanced circadian and sleep timing (Dewald‐Kaufmann et al., 2014; Saxvig et 
al., 2014; Sharkey et al., 2011) and/or that the thr e weekly sessions with a psychologist 
(including psychoeducation), in itself, provided benefit (Bowers, Clum, 1988). Saxvig and 
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however, total sleep time increased across treatment in the present study, so evidence for this 
hypothesis is limited. 
Morning Activity   
 This is the first study to investigate the efficacy of scheduled physical activity for the 
treatment of adolescent DSWPD. However, there was no objective evidence for increases in 
physical activity. Interactive motion-sensing video gaming has been considered more 
enjoyable than traditional physical activity for young adults (ie walking, running) (Graves et 
al., 2010). Although participants reported complying with morning activity, it is possible that 
daily physical activity was not of sufficient intensity or duration to have a therapeutic effect. 
Experimental studies have administered a three hr pulse of moderate (Baehr et al., 2003; 
Buxton et al., 1997; Van Reeth et al., 1994) or high intensity (Youngstedt et al., 2002) 
exercise, which is impractical to implement in clinical practice. However, there is some 
evidence that shorter durations of high intensity exercise could be as effective (Buxton et al., 
1997). Therefore, future studies could evaluate physical activity of a longer duration (eg 45-
60 min) and higher intensity (eg moderate-high intensity). Furthermore, future clinical trials 
could evaluate more practical forms of physical activity (ie walking/ cycling to school). 
Treatment of DSWPD 
 Although there is convincing evidence for the short-te m efficacy of chronobiological 
treatments for DSWPD, partial treatment success and relapse are common (Abu-Salah, 
Auger, 2013; Alvarez et al., 1992; Saxvig et al., 2014). 38% of our sample required 
additional treatment by the three month follow-up. As additional treatment was commonly 
chronobiological in nature (ie re-implementation of light therapy, evening exogenous 
melatonin, or a combination therof), it is possible that the continuation of light therapy may 
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Although treatment produced meaningful improvements in sleep and functioning, further 
research is needed to refine clinical practice guidelines for the treatment of DSWPD in young 
people.  
Limitations and Future Directions 
The limitations of our study are as follows: measure  of circadian timing were not 
taken (ie dim light melatonin onset, core body temprature nadir). Moreover, although 
participants were instructed to minimise natural light during LT, ambient light levels within 
participants’ homes were not measured. Although this data might have elucidated why there 
were no differences between the green and red LT conditi ns, the clinical application of this 
data is questionable. Additionally, wrist actigraphy was used to measure movement 
frequency, rather than more robust measures of physical activity, such as heart rate, or 
maximal oxygen consumption. Thus, although wrist actigraphy is an ecologically valid way 
of measuring activity, potential pitfalls may have included the ability of actigraphy to detect 
small differences in physical activity between the reatment groups. 
This trial recruited the largest number of adolescents and young adults to date, 
however, due to attrition, analyses conducted at the one and three month follow-ups may 
have been underpowered. As it is difficult to recruit a large number of adolescents for clinical 
research trials, it may be beneficial to conduct multicentre trials in the future.  
Future research could compare the relative effectivness of portable light devices with 
empirically established modes of bright light delivry (ie light boxes/ lamps) (Auger et al., 
2015). Alternatively, it would be worthwhile knowing whether the inclusion of an artificial 
light source (eg light box, lamp or glasses) in BLT is necessary. For example, dismantling 
research designs may help to elucidate what components of bright light therapy (eg evening 
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light therapy) drive improvements in sleep and daytime functioning for adolescents and 
young adults with DSWPD.  
Although the method and wavelength of light therapy were the focus of the present 
study, future clinical trials could vary the duration of daily light exposure. The duration of 
light therapy in the current study (ie 30-60 min) was in accordance with previous randomised 
controlled trials (Danielsson et al., 2015; Gradisar, Dohnt, et al., 2011; Saxvig et al., 2014) 
and clinical guidelines (Gradisar et al., 2014). Additionally, a recent trial has shown the 
duration of light therapy did not predict treatment ou comes (Danielsson et al., 2016). 
However, with a paucity of research investigating the effect of daily light therapy duration on 
the degree of circadian advance, further research is needed to increase our confidence in this 
standalone finding.  
Researchers could also aim to identify ‘risk factors’ (eg DSWPD severity, low 
motivation to change, repetitive negative thinking) for poor treatment outcome. The addition 
of cognitive behavioural therapy (Danielsson et al., 2015) to LT shows promise. However, 
identifying “risk factors” for poor treatment outcome, might allow for more effective case 
conceptualised treatment of DSWPD (ie treatment which focuses on the unique experience of 
the individual) (Dudley et al., 2011). Further refinement of treatment components should be a 
priority, with particular importance placed upon measuring long term outcomes, including 
relapse.  
Summary 
 In recent years, momentum is gaining for the evaluation of efficacious sleep 
treatments for adolescents and young adults. Findings from the present study add to existing 
literature supporting the use of light therapy for adolescent DSWPD (Danielsson et al., 2015; 
Gradisar, Dohnt, et al., 2011; Saxvig et al., 2014; Wilhelmsen-Langeland et al., 2013). 
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therapy (ie control conditions). Therefore, it is unclear what components of light therapy are 
the “active ingredients” of treatment and dismantling studies may be needed. As participants 
did not meaningfully increase physical activity, wecannot yet draw conclusions about the 
potential utility of morning physical activity. Notably, results suggest that relapse was 
common for many adolescents and young adults with DSWPD. Consequently, a number of 
priorities for future research have been highlighted. 
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• The trial compared short and long wavelength light therapy, with adjunct activity. 
• Adolescents had improved sleep timing, SOL and daytime functioning post-treatment. 
• There were no significant differences in outcomes between treatment groups. 
• Improvements were maintained, or improved upon (TST), at the three month follow-
up. 
• However, long-term relapse of DSWPD symptomology was common. 
 
